(Fujoshi Bijou)

GSK To Pay $105 Million To Settle Advair, Paxil, Wellbutrin Disputes

Drug biggie GlaxoSmithKline has been slapped with another huge settlement for its questionable marketing tactics. This time, the pharma company has agreed to pay $105 million to resolve claims made by attorneys general from 45 states regarding the selling of asthma drug Advair and antidepressants Paxil and Wellbutrin. [More]

GSK has released these photos of what authentic alli products should look like so that customers can be on the lookout for tampered-with packaging and fake products.

Weight-Loss Drug Alli Recalled Over Tampering Concerns

Big pharma biggie GlaxoSmithKline (GSK) has issued a recall all on all of its alli weight loss products in the U.S., including Puerto Rico, over concerns that packages may have been tampered with, resulting in some bottles containing something other than actual alli capsules. [More]

Walgreens Wants Everyone To Know It’s Continuing To Sell Cigarettes

Walgreens Wants Everyone To Know It’s Continuing To Sell Cigarettes

Earlier today, CVS surprised an awful lot of people by saying it would give up $2 billion a year in cigarette sales because it’s “the right thing for us to do for our customers and our company to help people on their path to better health.” Meanwhile, Walgreens, the nation’s largest drugstore chain, apparently wants the world to know that it will keep on selling tobacco. [More]

(Jason Gooljar)

GSK Theoretically Not Going To Pay Off Docs Anymore

Giant drug manufacturer GlaxoSmithKline announced today that it intends to stop paying doctors to prescribe more of the company’s drugs, a move that could possibly entice other large pharma companies to do the same. [More]

ProPublica's Dollars For Docs tool already lets you sort through available data from some companies.

Govt. To Publish Data On What Drug & Device Makers Pay To Individual Doctors & Hospitals

Want to know if your doctor is receiving free lunches and other perks from Pfizer, GSK or some other huge player in the pharmaceuticals or medical device business? Starting in Sept. 2014, that information will be made available to consumers courtesy of the federal government. [More]

DOJ Alleges Glaxo Paid Dr. Drew $275K To Talk Sexy About Wellbutrin

DOJ Alleges Glaxo Paid Dr. Drew $275K To Talk Sexy About Wellbutrin

Yesterday, pharma biggie GlaxoSmithKline settled for $3 billion with the Justice Dept. over a wide range of fraud-related allegations. Among all the documents involved in the case are claims by the DOJ that GSK paid TV/Radio personality Dr. Drew Pinsky a pile of cash to talk up off-label uses of the company’s antidepressant Wellbutrin, including a purported tie to causing multiple orgasms in females. [More]

GlaxoSmithKline Pleads Guilty & Will Pay U.S. $3 Billion To Resolve Fraud Allegations

GlaxoSmithKline Pleads Guilty & Will Pay U.S. $3 Billion To Resolve Fraud Allegations

In the largest health care fraud settlement in U.S. history, prescription drug giant GlaxoSmithKline is set to plead guilty and pay $3 billion to the U.S. government. The settlement will resolve federal criminal and civil inquiries about things ranging from the company’s illegal promotion of some of its products to its failure to report safety data and alleged false price reporting. [More]

GSK Sued For Fraudulently Delaying Generic Version Of Wellbutrin

GSK Sued For Fraudulently Delaying Generic Version Of Wellbutrin

A class action lawsuit has been filed accusing GlaxoSmithKline of lying to the Patent office and dickering with fake patent litigation against generic drug makers to fraudulently stymie generic versions of Wellbutrin from hitting the market. The lawsuit applies to people who directly bought Wellbutrin from GSK in 100 or 150mg hits between Jan 24, 2002 and June 30, 2006. Obviously, the long GSK could keep a generic version of their drug off the market, the more money they could make. People interested in joining could probably contact the firm of Roda and Nast, lead plaintiff team, for more information.

Glaxo Buys Aging Retardation Drug Company

Glaxo Buys Aging Retardation Drug Company

GlaxoSmithKline is buying a U.S. biotechnology company that is researching resveratrol, the chemical compound found in red wine that may retard the aging process. The CEO of the company says that “drugs that mimic resveratrol, by activating enzymes called sirtuins, could ‘treat in a safe, natural new way, many of the major killers of western society.'” We can’t wait to see the commercials that GSK puts out for this one.

GlaxoSmithKline Spams Its Critics

GlaxoSmithKline Spams Its Critics

Part of GlaxoSmithKiline’s marketing campaign appears to take place in comment spam. This is old news: Jack Silbert over at Stay Free! Daily blew that wide open over a year ago, getting the news picked up by USA Today!

Paxil Unafraid to Demonstrate Bling in ’98 Memo

Paxil Unafraid to Demonstrate Bling in ’98 Memo

You may recall Paxil as the inspiration for several Law & Order episodes. In 2004, NY Attorney General began proceedings against Paxil makers GlaxoSmithKline after the company suppressed five internal studies between 1998 and 2002 revealing links between the drug and incidences of suicide among its users, especially children and young adults.